Selda Pelin Kartal

Selda Pelin Kartal

Auto-generated profile, based on publicly available information

Selda Pelin Kartal

Ankara Etlik Şehir Hastanesi

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Dermatologic Therapy
Verified
Journal Article
Open access
PDF file
SKSelda Pelin Kartal
Selda Pelin Kartal
GÇGökçen Çelik
Gökçen Çelik
NSNeslihan Sendur
Neslihan Sendur
SASema Aytekin
Sema Aytekin
SSServer Serdaroğlu
Server Serdaroğlu
EAErkan Alpsoy
Erkan Alpsoy
COVID‐19 pandemic has a significant impact on public health, whether directly or indirectly. The first case was seen in Turkey on March 11, and the World Health Organization (WHO) declared a pandemic on March 12, 2020. The study aimed to document the effect of pandemic on dermatology outpatient clinics in Turkey. Fifteen tertiary hospitals from 13 provinces were included in the study, which was conducted between January 12 and May 12, 2020. The International Codes of Diseases (ICD‐10) categories and patients' characteristics were evaluated before and after the pandemic. A total of 164 878 patients, 133 131 before and 31 747 after the pandemic, were evaluated. The daily hospital applications were found reduced by 77%. The three of the most frequent diagnoses; dermatitis, acne, and psoriasis remained unchanged after the pandemic. While the frequency of herpes zoster, scabies, urticaria, pityriasis rosea and sexually transmitted diseases increased significantly; allergic and irritant contact dermatitis decreased after the pandemic. The applications regarding cutaneous neoplasms were considerably reduced during the pandemic, and this effect was more pronounced in cities with higher COVID incidence. The pandemic caused a noteworthy reduction in the number of patients accessing dermatological care. The pandemic caused significant changes in the frequency of a wide range of dermatological diseases. The application of cutaneous neoplasms is considerably reduced after the pandemic, and this effect was more pronounced in cities where pandemics are frequent. Therefore, the pandemic has resulted on numerous impacts on many critical issues in dermatology and dermatological care.

13 April 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
APA. Kara Polat
A. Kara Polat
EAE. Alpsoy
E. Alpsoy
GKG. Kalkan
G. Kalkan
SAS. Aytekin
S. Aytekin
DUD. Uçmak
D. Uçmak
AAA. Ataseven
A. Ataseven

1 February 2018 in Dermatologic Surgery
Verified
Journal Article
Closed access
SKSelda Pelin Kartal
Selda Pelin Kartal
FCFiliz Canpolat
Filiz Canpolat
MGMuzeyyen Gonul
Muzeyyen Gonul
CECan Ergin
Can Ergin
ZGZeynep Bsc Gencturk
Zeynep Bsc Gencturk
BACKGROUND: Psoriasis is a chronic inflammatory skin disease in which lesions display angiogenesis and increased vascularity. OBJECTIVE: The long-pulsed 1,064-nm neodymium:yttrium-aluminum-garnet (Nd:YAG) laser treats vascular lesions which suggests that it might also be used to treat nail psoriasis. METHODS: Sixteen patients (10 males and 6 females) with isolated nail psoriasis or nail with only mild cutaneous involvement were enrolled in the study. Nails were treated for 3 sessions with long-pulsed 1,064-nm Nd:YAG laser once monthly. During the course of the treatment, nail bed and matrix Nail Psoriasis Severity Index (NAPSI) scores were recorded. RESULTS: The mean baseline NAPSI score was 26 ± 7.2. The means of total NAPSI scores after the first, second, and third treatment sessions were as follows: 22 ± 6.6, 13 ± 6, and 5.7 ± 4.3, respectively. The decline in NAPSI score was statistically significant. At the end of the 3 treatment sessions, both nail bed and matrix lesions significantly responded to Nd:YAG laser treatment. CONCLUSION: The Nd:YAG laser is a promising treatment option for nail psoriasis.

1 January 2020 in Annals of Dermatology
Verified
Journal Article
Open access
PDF file
EAErkan Alpsoy
Erkan Alpsoy
MPMualla Polat
Mualla Polat
IYIbrahim Halil Yavuz
Ibrahim Halil Yavuz
PKPelin Kartal
Pelin Kartal
DBDidem Didar Balci
Didem Didar Balci
YSYesim Senol
Yesim Senol
Alpsoy E, et al. Ann Dermatol. 2020 Jun;32(3):181-188. https://doi.org/10.5021/ad.2020.32.3.181

1 January 2008 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
SDSelda Pelin Kartal Durmazlar
Selda Pelin Kartal Durmazlar
AAAhmet Akgul
Ahmet Akgul
FEFatma Eskioglu
Fatma Eskioglu
Objective. Our aim was to evaluate the significance of homocysteine (Hcy) in Behcet′s disease (BD) and the association of elevated Hcy levels associated with the indices of inflammation in BD. Methods. Untreated 70 patients with BD and 33 healthy individuals were included into the study. Hcy, tumor necrosis alpha (TNF‐α), C‐reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were evaluated with respect to activity and specific individual clinical manifestations of the disease. Results. Hcy levels were found significantly elevated in active BD when compared to inactive BD and healthy controls. Hcy levels were found to have high correlation with the number of active clinical manifestations increased. A significant positive correlation was found between serum Hcy and TNF‐α levels, CRP, and ESR. Hcy was found to be the best predictor of TNF‐α among other parameters. Conclusion. Hcy may involve in the pathogenesis of BD by inducing inflammation.

1 January 2008 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
SDSelda Pelin Kartal Durmazlar
Selda Pelin Kartal Durmazlar
FEFatma Eskioglu
Fatma Eskioglu
ZBZeliha Bodur
Zeliha Bodur
Hyperkeratosis of the nipple and areola is a rare disorder characterized by verrucous thickening and brown pigmentation of the nipple and areola with unknown etiology. Although it is a generally asymptomatic disorder, cosmetic disfiguring creates a real psychological problem for young women. Moreover, treatment regimens are not satisfactory. Surgical treatment has been suggested as an initial treatment in resistant and recurrent cases because of the relapses seen after medical treatment. We report a case who responded satisfactorily to low-dose acitretin and topical calcipotriol treatment with no relapses during 2 years of follow-up. Among all reported medical treatments and interventional approaches, including surgery, this is the first patient reported with 2 years of remission.